Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures

被引:78
作者
Tuan, TL
Wu, HY
Huang, EY
Chong, SSN
Laug, W
Messadi, D
Kelly, P
Le, A
机构
[1] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Surg, Los Angeles, CA 90027 USA
[2] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pediat, Los Angeles, CA 90027 USA
[3] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA
[4] Charles R Drew Univ Med & Sci, Los Angeles, CA 90059 USA
关键词
D O I
10.1016/S0002-9440(10)64292-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Proteolytic degradation of the provisional fibrin matrix and subsequent substitution by fibroblast-produced collagen are essential features of injury repair. Immunohistochemical studies revealed that although dermal fibroblasts of normal scars and keloids expressed both urokinase type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1), keloid fibroblasts had a much higher PAI-1 expression. In long-term three-dimensional fibrin gel cultures (the in vitro fibroplasia model), normal fibroblasts expressed moderate and modulated activity levels of uPA and PAI-1. In contrast, keloid fibroblasts expressed a persistently high level of PAI-1 and a low level of uPA. The high PAI-1 activity of keloid fibroblasts correlated with their elevated collagen accumulation in fibrin gel cultures. Substituting collagen for fibrin in the gel matrix resulted in increased uPA activity and reduced collagen accumulation of keloid fibroblasts. Furthermore, decreasing PAI-1 activity of keloid fibroblasts in fibrin gel cultures with anti-PAI-1-neutralizing antibodies also resulted in a reduction in collagen accumulation by keloid fibroblasts. Cumulatively, these results suggest that PAI-1 overexpression is a consistent feature of keloid fibroblasts both in vitro and in vivo, and PAI-1 may play a causative role in elevated collagen accumulation of keloid fibroblasts.
引用
收藏
页码:1579 / 1589
页数:11
相关论文
共 70 条
[41]   CHANGES IN PROCOAGULANT AND FIBRINOLYTIC GENE-EXPRESSION DURING BLEOMYCIN-INDUCED LUNG INJURY IN THE MOUSE [J].
OLMAN, MA ;
MACKMAN, N ;
GLADSON, CL ;
MOSER, KM ;
LOSKUTOFF, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1621-1630
[42]  
Parks WC, 1998, BIOL EXTRAC, P263
[43]   ACTIVATION OF COLLAGEN GENE-EXPRESSION IN KELOIDS - COLOCALIZATION OF TYPE-I AND TYPE-VI COLLAGEN AND TRANSFORMING GROWTH FACTOR-BETA-1 MESSENGER-RNA [J].
PELTONEN, J ;
HSIAO, LL ;
JAAKKOLA, S ;
SOLLBERG, S ;
AUMAILLEY, M ;
TIMPL, R ;
CHU, ML ;
UITTO, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (02) :240-248
[44]   A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice [J].
Ploplis, VA ;
Wilberding, J ;
McLennan, L ;
Liang, Z ;
Cornelissen, I ;
DeFord, ME ;
Rosen, ED ;
Castellino, FJ .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (03) :703-708
[45]   THE CELL BIOLOGY OF THE PLASMINOGEN SYSTEM [J].
PLOW, EF ;
HERREN, T ;
REDLITZ, A ;
MILES, LA ;
HOOVERPLOW, JL .
FASEB JOURNAL, 1995, 9 (10) :939-945
[46]  
Rifkin DB, 1997, CIBA F SYMP, V212, P105
[47]   Molecular and cell biology of TGF-β [J].
Roberts, AB .
MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) :111-119
[48]   Impaired wound healing in mice with a disrupted plasminogen gene [J].
Romer, J ;
Bugge, TH ;
Pyke, C ;
Lund, LR ;
Flick, MJ ;
Degen, JL ;
Dano, K .
NATURE MEDICINE, 1996, 2 (03) :287-292
[49]  
ROSSERT J, 1996, STRUCTURE SYNTHESIS, P127
[50]  
RUSSELL SB, 1989, J BIOL CHEM, V264, P13730